Antiarrythmics Flashcards
Class 1A antiarrythmics
Na+ channel blockers
Decrease slope of phase 0 (medium)
Increase action potential duration
Disopyramide, Quinidine, Procainamide
Atrial and Ventricular arrthymias
Toxicity: Prolonged QT (Torsades de pointes)
Procainamide: SLE-like symptoms
Quinidine
Class IA Na+ channel blockers
Decrease slope of phase 0 (medium)
Increase action potential duration
Atrial and Ventricular arrthymias
Toxicity: Prolonged QT (Torsades de pointes)
Disopyramide
Class IA Na+ channel blockers
Decrease slope of phase 0 (medium)
Increase action potential duration
Atrial and Ventricular arrthymias
Toxicity: Prolonged QT (Torsades de pointes)
Procainamide
Class IA Na+ channel blockers
Decrease slope of phase 0 (medium)
Increase action potential duration
Atrial and Ventricular arrthymias
Toxicity: Prolonged QT (Torsades de pointes)
SLE-like symptoms
Class 1B antiarrythmics
Na+ channel blockers
Lidocaine, Tocainide, Mexiletine
Decrease slope of phase 0
Shortens action potential length
Acute ventricular arrythmias (post-MI)
and digitalis-induced arrythmias
Class 1 C antiarrythmics
Na+ channel blocker
Flecainide, propafenone
Decrease slope of phase 0
No change in action potential duration
Ventricular tachycardia that progress to VF
or intracible SVT
Contraindicated post-MI
Lidocaine
Class IB Na+ channel blockers
Decrease slope of phase 0
Shortens action potential length
Acute ventricular arrythmias (post-MI)
and digitalis-induced arrythmias
Tocainide
Class IB Na+ channel blockers
Decrease slope of phase 0
Shortens action potential length
Acute ventricular arrythmias (post-MI)
Mexiletine
Class IB Na+ channel blockers
Decrease slope of phase 0
Shortens action potential length
Acute ventricular arrythmias (post-MI)
and digitalis-induced arrythmias
Flecainide
Class IC Na+ channel blocker
Decrease slope of phase 0
No change in action potential duration
Ventricular tachycardia that progress to VF
or intracible SVT
Contraindicated post-MI
Propafenone
Na+ channel blocker
Decrease slope of phase 0
No change in action potential duration
Ventricular tachycardia that progress to VF
or intracible SVT
Contraindicated post-MI
Class II antiarrythmics
Beta-blockers
Decrease cAMP, decrease Ca++ currents
Decrease slope of phase 4 in pacemakers
Increase PR interval (slower AV node conduction)
Ventricular tach, SVT, atrial fibrillation and atrial flutter
Class III antiarrythmics
K+ channel blocker